Debatable points of using angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with COVID-19

The COVID-19 pandemic is a serious threat to global health. The infection mechanism is the binding of SARS-CoV-2 to angiotensin-converting enzyme 2 (ACE2) and internalization of the complex by the host cell. ACE inhibitors/angiotensin receptor antagonists (ARA) are known to increase ACE2 expression...

Full description

Bibliographic Details

Published in:	Кардиоваскулярная терапия и профилактика
Main Authors:	O. M. Drapkina, L. E. Vasilyeva
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2020-07-01
Subjects:	covid-19 sars-cov-2 angiotensin converting enzyme inhibitors angiotensin receptor antagonists angiotensin converting enzyme 2 cardiovascular diseases
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2580